International Headache Society global practice recommendations for the acute pharmacological treatment of migraine.
Обработка статьи · этапы, ошибки и управление
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Puledda Francesca, Sacco Simona, Diener Hans-Christoph, Ashina Messoud, Al-Khazali Haidar M, Ashina Sait, Burstein Rami, Liebler Eric, Cipriani Andrea, Chu Min Kyung, Cocores Alexandra, Dodd-Glover Freda, Ekizoğlu Esme, Garcia-Azorin David, Göbel Carl, Goicochea Maria Teresa, Hassan Amr, Hirata Koichi, Hoffmann Jan, Jenkins Bronwyn, Kamm Katharina, Lee Mi Ji, Ling Yu-Hsiang, Lisicki Marco, Martinelli Daniele, Monteith Teshamae S, Ornello Raffaele, Ozge Aynur, Peres Mario, Pozo-Rosich Patricia, Romanenko Volodymyr, Schwedt Todd J, Souza Marcio Nattan P, Takizawa Tsubasa, Terwindt Gisela M, Thuraiaiyah Janu, Togha Mansoureh, Vandenbussche Nicolas, Wang Shuu-Jiun, Yu Shengyuan, Tassorelli Cristina
Аннотация
METHODS: An IHS steering committee developed a list of clinical questions based on practical issues in the management of migraine. A selected group of international senior and junior headache experts developed the recommendations, following expert consensus and the review of available national and international headache guidelines and guidance documents. Following the initial search, a bibliography of twenty-one national and international guidelines was created and reviewed by the working group.
RESULTS: A total of seventeen questions addressing different aspects of acute migraine treatment have been outlined. For each of them we provide an optimal recommendation, to be used whenever possible, and an essential recommendation to be used when the optimal level cannot be attained.
CONCLUSION: Adoption of these international recommendations will improve the quality of acute migraine treatment around the world, even where pharmacological options remain limited.